Clopidogrel Appropriate for PCI in Liver Transplant Candidates Clopidogrel Appropriate for PCI in Liver Transplant Candidates
In patients with decompensated cirrhosis undergoing percutaneous coronary intervention (PCI), clopidogrel safely inhibits platelet aggregation, according to a small study of liver-transplant candidates.Reuters Health Information
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Cardiology News Source Type: news
More News: Angioplasty | Cardiology | Cirrhosis | Clopidogrel | Coronary Angioplasty | Heart | Liver | Liver Transplant | Percutaneous Coronary Intervention | Plavix | Study | Surgery | Transplant Surgery | Transplants | Urology & Nephrology